Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Eleonora Pellè, Jonathan Strosberg
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3655-3655
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States
Zihan Xu, Li Wang, Shuang Dai, et al.
JAMA Network Open (2021) Vol. 4, Iss. 9, pp. e2124750-e2124750
Open Access | Times Cited: 162
Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites
Silvia Uccella, Stefano La Rosa, Jasna Metović, et al.
Endocrine Pathology (2021) Vol. 32, Iss. 1, pp. 192-210
Closed Access | Times Cited: 59
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
Benjamin White, Beth Russell, Sebastiaan Remmers, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1863-1863
Open Access | Times Cited: 16
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
Francesco Panzuto, Stefano Partelli, Davide Campana, et al.
Endocrine (2024) Vol. 84, Iss. 1, pp. 42-47
Open Access | Times Cited: 5
Gastrointestinal side effects of somatostatin analogs in neuroendocrine tumors: a focused review
Matteo Marasco, Elisabetta Dell'Unto, Alessandro Laviano, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1737-1744
Open Access | Times Cited: 5
Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)
Grigoris Effraimidis, Ulrich Knigge, Maria Rossing, et al.
Seminars in Cancer Biology (2021) Vol. 79, pp. 141-162
Closed Access | Times Cited: 32
"Present and future of immunotherapy in Neuroendocrine Tumors"
Manuela Albertelli, Andrea Dotto, Federica Nista, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 3, pp. 615-636
Open Access | Times Cited: 31
PANCREATIC NEUROENDOCRINE NEOPLASMS (pNENs): GENETIC AND ENVIRONMENTAL BIOMARKERS FOR RISK OF OCCURRENCE AND PROGNOSIS
Matteo Tacelli, Manuel Gentiluomo, Paolo Biamonte, et al.
Seminars in Cancer Biology (2025)
Closed Access
Selecting optimal therapy for advanced nonfunctional pancreatic neuroendocrine tumors: latest research and therapeutic advances
Ruba Alchaikh Hassan, Arti C. Patel, Constantin A Dasanu
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)
Jianming Xu
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 25
New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Feng Yin, Zihao Wu, Jinping Lai
World Journal of Gastroenterology (2022) Vol. 28, Iss. 17, pp. 1751-1767
Open Access | Times Cited: 14
Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors
Kristen McClellan, Emerson Y. Chen, Adel Kardosh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4769-4769
Open Access | Times Cited: 12
Immunotherapy in Neuroendocrine Neoplasms: A Diamond to Cut
Esmeralda García‐Torralba, Esther Garcia-Lorenzo, Bernard Doger, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2530-2530
Open Access | Times Cited: 2
Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors
Xiuhua Lu, Shibin Yan, Kelly Koral, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 9, pp. 917-926
Closed Access | Times Cited: 13
The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
Francesco Panzuto, Claudio Ricci, Maria Rinzivillo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6127-6127
Open Access | Times Cited: 9
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
Wei-Xuan Pan, Xin-Mu Zhang, Shaolong Hao, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4174-4185
Open Access | Times Cited: 5
Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors
Clarisse Dromain, Marianne Pavel, Maxime Ronot, et al.
Future Oncology (2023) Vol. 19, Iss. 32, pp. 2171-2183
Open Access | Times Cited: 4
Small Intestinal, Colorectal, and Appendicular Neuroendocrine Tumors
Lowell Anthony, Garima Gupta, Aman Chauhan
Springer eBooks (2024), pp. 363-405
Closed Access | Times Cited: 1
Immunotherapy in Gastroenteropancreatic Neuroendocrine Neoplasia
Ioana Ilie, Carmen Emanuela Georgescu
Neuroendocrinology (2021) Vol. 113, Iss. 2, pp. 262-278
Open Access | Times Cited: 10
“The past is a different country, they do things differently there”: using the SEER data-base to assess prognosis in neuroendocrine tumours
Krystallenia Alexandraki, Maria Chiara Zatelli, Ashley Grossman
Endocrine (2022) Vol. 75, Iss. 3, pp. 725-727
Closed Access | Times Cited: 6
Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
Taymeyah Al‐Toubah, Jonathan Strosberg, Julie Hallanger‐Johnson, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications
E Lauricella, Barbara Mandriani, Federica Cavallo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trial
Marta Ligero, Jorge Hernando, Eric Delgado, et al.
BJC Reports (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 2
Advances in medical treatment for pancreatic neuroendocrine neoplasms
Yuanliang Li, Zixuan Cheng, Fuhuan Yu, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 20, pp. 2163-2175
Open Access | Times Cited: 4
Clinical Challenges in the Management of Neuroendocrine Tumors
Francesco Panzuto
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 257-257
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top